Zim Laboratories Hits New 52-Week Low at Rs. 69.89

Zim Laboratories, a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs. 69.89 today, October 15, 2025. This decline marks a significant downturn for the company, which has seen its stock price fall by 2.61% over the past two days. The stock has consistently underperformed, trailing behind its sector by 0.51% today.
In the broader market context, the Sensex has been on an upward trajectory, gaining 388.76 points to reach 82,586.01, reflecting a bullish sentiment among investors. However, Zim Laboratories' performance starkly contrasts with this trend, as it has recorded a substantial 37.85% decline over the past year, compared to the Sensex's modest gain of 0.94%.

The company's financial metrics reveal ongoing challenges, including a significant drop in net sales by 12.3% and a negative profit after tax of Rs. -1.87 crore. With a return on capital employed (ROCE) of just 7.99%, Zim Laboratories continues to face hurdles in achieving sustainable growth, as evidenced by its negative results over the last five quarters.